NHS England is rolling out a new pill that triples the chances of quitting smoking. With the goal of saving lives and creating a smoke-free generation, this game-changing treatment could make a significant impact on public health.
(c) Freestocks Org/Pexels CC0
(c) Freestocks Org/Pexels CC0

NHS lanza una píldora revolucionaria para salvar la vida de fumadores

THE GUARDIAN

Con el objetivo de salvar vidas y crear una generación libre de humo, la salud pública en Inglaterra está lanzando una nueva pastilla que ha demostrado triplicar el exito de personas que intentan dejar de fumar.

Read Full Story

Entradas relacionadas

Los Más Leídos

A recent Carbon Brief study shows China’s carbon dioxide emissions have remained unchanged or declined for 18 straight months, thanks in part to a surge in solar (+240 GW) and wind (+61 GW) capacity and a 5% drop in transport emissions.
Las emisiones de CO₂ de China no suben desde hace 18 meses, revela análisis
Scientists at TU Wien have developed a non-toxic “deep-eutectic” solvent that separates blended fabrics — like cotton-polyester mixes — within minutes. Cotton stays intact and polyester is recovered almost fully, offering a near-complete recycling method for textiles that were once nearly impossible to reclaim.
Un disolvente no tóxico podría revolucionar el reciclaje de tejidos mezclados
At COP30 in Belém, Brazil officially created ten new Indigenous territories, including some overlapping Amazon National Park. The move, issued via presidential decree, adds legal protection to lands of groups like the Munduruku and Guarani-Kaiowá during a summit marked by protests.
Brasil reconoce 10 nuevos territorios indígenas en medio de protestas en la COP30
Researchers at the University of Cologne have discovered a powerful antibody — 04_A06 — that neutralizes around 98.5 % of over 300 tested HIV strains. In lab experiments the antibody reduced viral load to undetectable levels — a major step toward broad-spectrum therapies for prevention and treatment worldwide.
Gran avance contra el VIH: anticuerpo neutraliza casi todas las variantes